ABSTRACT
Introducción: La angioembolización selectiva es una alternativa no quirúrgica para controlar el sangrado facial traumático. Caso clínico: Informamos el caso de un paciente con herida facial por proyectil de arma de fuego tratado con angioembolización selectiva como adyuvante al control de daños, con lo que se logró detener la hemorragia. Conclusiones: La angioembolización selectiva es un valioso adyuvante en la detención del sangrado facial traumático.
BACKGROUND: Selective angioembolization (SAE) is a nonsurgical alternative for controlling traumatic facial bleeding. CLINICAL CASE: We report a case of a patient who sustained a facial gunshot wound. The patient was treated with SAE as an adjuvant to damage control, leading to the arrest of hemorrhage. CONCLUSIONS: SAE is a valuable adjuvant in arresting traumatic facial bleeding.
Subject(s)
Humans , Male , Aged , Embolization, Therapeutic/methods , Wounds, Gunshot/complications , Hemorrhage/etiology , Hemorrhage/therapy , Facial Injuries/complicationsABSTRACT
BACKGROUND: Uncontrolled bleeding leads to 40-86% of preventable deaths due to trauma. Use of NovoSeven (rFVIIa) in trauma is promising, although data supporting its utilization are limited. CASE REPORT: We report the case of a patient who sustained a penetrating grade V cardiac injury (AAST-OIS) and presented postoperative massive coagulopathic bleeding arrested by the administration of platelet pools and NovoSeven. DISCUSSION: This report represents our initial experience and the very first case of successful use of NovoSeven for the treatment of traumatic coagulopathic hemorrhage at the Central Military Hospital in Mexico City. A further prospective trial justifying its use in our institution is warranted.